These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28495863

  • 21. Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients.
    Wlazeł RN, Szadkowska I, Bartnicki P, Rośniak-Bąk K, Rysz J.
    Int Urol Nephrol; 2018 Feb; 50(2):339-345. PubMed ID: 29313168
    [Abstract] [Full Text] [Related]

  • 22. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis.
    Huang F, Li Y, Xu R, Cheng A, Lv Y, Liu Q.
    Mediators Inflamm; 2020 Feb; 2020():7850179. PubMed ID: 32322165
    [Abstract] [Full Text] [Related]

  • 23. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
    Nusshag C, Rupp C, Schmitt F, Krautkrämer E, Speer C, Kälble F, Tamulyte S, Bruckner T, Zeier M, Reiser J, Weigand MA, Uhle F, Merle U, Morath C, Brenner T.
    Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
    [Abstract] [Full Text] [Related]

  • 24. Serum β-trace protein and risk of mortality in incident hemodialysis patients.
    Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1435-45. PubMed ID: 22745274
    [Abstract] [Full Text] [Related]

  • 25. Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease.
    Al-Badri A, Tahhan AS, Sabbak N, Alkhoder A, Liu C, Ko YA, Vaccarino V, Martini A, Sidoti A, Goodwin C, Ghazzal B, Beshiri A, Murtagh G, Mehta PK, Quyyumi AA.
    J Am Heart Assoc; 2020 Apr 21; 9(8):e015515. PubMed ID: 32301366
    [Abstract] [Full Text] [Related]

  • 26. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug 21; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease.
    Füller D, Liu C, Ko YA, Alkhoder AA, Desai SR, Almuwaqqat Z, Patel SA, Ejaz K, Kauser T, Martini MA, Alvi Z, Mehta PK, Sperling LS, Quyyumi AA.
    Eur J Prev Cardiol; 2024 Mar 27; 31(5):521-528. PubMed ID: 37788634
    [Abstract] [Full Text] [Related]

  • 29. Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.
    Hayek SS, Landsittel DP, Wei C, Zeier M, Yu ASL, Torres VE, Roth S, Pao CS, Reiser J.
    J Am Soc Nephrol; 2019 Jul 27; 30(7):1305-1313. PubMed ID: 31171572
    [Abstract] [Full Text] [Related]

  • 30. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM, Kovesdy CP, You AS, Sim JJ, Soohoo M, Streja E, Molnar MZ, Amin AN, Abbott K, Nguyen DV, Kalantar-Zadeh K.
    Am J Kidney Dis; 2018 Nov 27; 72(5):701-710. PubMed ID: 30037725
    [Abstract] [Full Text] [Related]

  • 31. Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.
    Sommerer C, Zeier M, Morath C, Reiser J, Scharnagl H, Stojakovic T, Delgado GE, März W, Kleber ME.
    Sci Rep; 2019 Jan 24; 9(1):475. PubMed ID: 30679668
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
    Jhee JH, Nam BY, Lee CJ, Park JT, Han SH, Kang SW, Park S, Yoo TH.
    J Am Heart Assoc; 2021 Jan 05; 10(1):e017225. PubMed ID: 33325248
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis.
    Wu W, Cui Y, Hu J, Liao R, Li S, Mo L, Xu L, Chen Y, Lian Z, Tian X, Li Z, Li R, Zhang L, Liang H, Ma J, Lin T, Feng Z, Dong W, Ke G, Ge P, Ye Z, Wang W, Zhang B, Shi W, Liang X, Liu S.
    Kidney Blood Press Res; 2018 Jan 05; 43(3):664-672. PubMed ID: 29734173
    [Abstract] [Full Text] [Related]

  • 37. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
    Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A.
    JACC Heart Fail; 2017 Apr 05; 5(4):268-277. PubMed ID: 28359415
    [Abstract] [Full Text] [Related]

  • 38. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.
    Borné Y, Persson M, Melander O, Smith JG, Engström G.
    Eur J Heart Fail; 2014 Apr 05; 16(4):377-83. PubMed ID: 24464777
    [Abstract] [Full Text] [Related]

  • 39. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
    Zhou Y, Ren J, Li P, Ma R, Zhou M, Zhang N, Kong X, Hu Z, Xiao X.
    Arch Med Res; 2019 Jul 05; 50(5):249-256. PubMed ID: 31593848
    [Abstract] [Full Text] [Related]

  • 40. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Pickard MA, Henderson DL, Sadler MV, Courchene LM, Jordan JR, Balderston SS, Graham AD, Mauck VL, Russell GB, Bleyer AJ.
    Clin J Am Soc Nephrol; 2011 Jul 05; 6(7):1635-43. PubMed ID: 21597024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.